Chronic diseases require extensive ongoing medical care at an ever-increasing cost. From heart disease to epilepsy, this Market Map looks at the startups transforming how providers diagnose, monitor, and treat chronic diseases.
The management of chronic diseases is complicated and costly — and it’s only getting worse.
Nearly three-quarters of deaths worldwide result from chronic diseases, such as heart disease and cancer, according to the WHO. In the US alone, the CDC estimates care for people with chronic conditions accounts for 90% of the nation’s $4.1T annual healthcare spending. As the world’s population ages, these costs are expected to increase.
In response, providers are turning to technology solutions that promise to diagnose chronic diseases more quickly, monitor them more closely, and treat them more effectively. These solutions range from vocal biomarker analysis to diagnose Alzheimer’s disease to sensor-based insoles that monitor stroke rehabilitation.
Using CB Insights data, we identified 151 early-stage companies focused on enhancing care for 9 of the most common chronic diseases.
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
